Olive leaf supplements showed no clear metabolic benefit in pooled trials
Continuous-intake trials found no statistically or clinically significant glucose or lipid effects; short-term responses and inflammation evidence remained uncertain.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This abstract-based review did not find support for metabolic benefits from olive leaf extract or oleuropein in pooled continuous-intake trials. Short-term studies gave mixed results that could not be pooled, and evidence on inflammation was limited. The findings do not establish that every formulation or use pattern has no effect.
The abstract provides no pooled effect estimates, confidence intervals, doses, or treatment lengths. Evidence on inflammatory markers was scarce and rated low certainty.
What researchers found
Blood glucose and lipid outcomes
Continuous-intake trials comparing extract or oleuropein with placebo or control; treatment lengths were not reported. Effects were neither statistically nor clinically significant.
Why trial formats mattered
Short-term crossover studies assessed glucose and insulin responses after meals, but their results differed too much to combine. The pooled analysis instead used continuous-intake trials with parallel treatment groups.
What the outcomes can tell us
The review examined glucose regulation, blood lipids, and inflammatory markers. These are measured biological outcomes; the abstract does not report whether supplementation changed symptoms or longer-term health events.
The original publication
Metabolic and inflammatory effects of oleuropein and olive leaf extract: a systematic review and meta-analysis.
Câmara Rocha Menezes R, Peres KK, da Mata IR et al.
Food Funct · 2026
- PubMed ID
- 41848522
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.